Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond

Gennaro Gadaleta-Caldarola; Rosa Divella; Antonio Mazzocca; Stefania Infusino; Emanuela Ferraro; Gianfranco Filippelli; Antonella Daniele; Carlo Sabbà; Ines Abbate; Mario Brandi

doi:10.2217/fon.15.161

Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond

Gennaro Gadaleta-Caldarola, Rosa Divella, Antonio Mazzocca, Stefania Infusino, Emanuela Ferraro, Gianfranco Filippelli, Antonella Daniele, Carlo Sabbà, Ines Abbate, Mario Brandi

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2263-2266
Number of pages	4
Journal	Future Oncology
Volume	11
Issue number	16
DOIs	https://doi.org/10.2217/fon.15.161
Publication status	Published - Aug 1 2015

Keywords

HCC
multikinase inhibitors
RAS/RAF/MEK/ERK pathway
sorafenib

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.2217/fon.15.161

Cite this

Sorafenib : The gold standard therapy in advanced hepatocellular carcinoma and beyond. / Gadaleta-Caldarola, Gennaro; Divella, Rosa; Mazzocca, Antonio; Infusino, Stefania; Ferraro, Emanuela; Filippelli, Gianfranco; Daniele, Antonella; Sabbà, Carlo; Abbate, Ines; Brandi, Mario.

In: Future Oncology, Vol. 11, No. 16, 01.08.2015, p. 2263-2266.

Research output: Contribution to journal › Article › peer-review

@article{198113591cee4bf2a6c091e9334fc246,

title = "Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond",

keywords = "HCC, multikinase inhibitors, RAS/RAF/MEK/ERK pathway, sorafenib",

author = "Gennaro Gadaleta-Caldarola and Rosa Divella and Antonio Mazzocca and Stefania Infusino and Emanuela Ferraro and Gianfranco Filippelli and Antonella Daniele and Carlo Sabb{\`a} and Ines Abbate and Mario Brandi",

year = "2015",

month = aug,

day = "1",

doi = "10.2217/fon.15.161",

language = "English",

volume = "11",

pages = "2263--2266",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Future Medicine Ltd.",

number = "16",

}

TY - JOUR

T1 - Sorafenib

T2 - The gold standard therapy in advanced hepatocellular carcinoma and beyond

AU - Gadaleta-Caldarola, Gennaro

AU - Divella, Rosa

AU - Mazzocca, Antonio

AU - Infusino, Stefania

AU - Ferraro, Emanuela

AU - Filippelli, Gianfranco

AU - Daniele, Antonella

AU - Sabbà, Carlo

AU - Abbate, Ines

AU - Brandi, Mario

PY - 2015/8/1

Y1 - 2015/8/1

KW - HCC

KW - multikinase inhibitors

KW - RAS/RAF/MEK/ERK pathway

KW - sorafenib

UR - http://www.scopus.com/inward/record.url?scp=84939188783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939188783&partnerID=8YFLogxK

U2 - 10.2217/fon.15.161

DO - 10.2217/fon.15.161

M3 - Article

C2 - 26260805

AN - SCOPUS:84939188783

VL - 11

SP - 2263

EP - 2266

JO - Future Oncology

JF - Future Oncology

SN - 1479-6694

IS - 16

ER -